SUTRO BIOPHARMA, INC. Debt Securities, Available-for-sale
Financial Statements › Balance Sheet › Assets › Investments
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2026-08-12
- 2026-06-30: Debt Securities, Available-for-sale $162.67M.
- 2026-03-31: Debt Securities, Available-for-sale $202.19M.
- 2025-12-31: Debt Securities, Available-for-sale $134.63M.
- 2025-09-30: Debt Securities, Available-for-sale $166.70M.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2026-06-30 | $162.67M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $202.19M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $134.63M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $166.70M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $203.13M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $247.85M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $313.41M 10-K · filed 2026-03-23 |
| 2024-09-30 | $388.09M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $361.60M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $265.64M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $329.56M 10-K · filed 2025-03-13 |
| 2023-09-30 | $318.99M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $357.81M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $250.10M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $298.41M 10-K · filed 2024-03-25 |
| 2022-09-30 | $286.45M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $182.68M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $191.56M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $228.57M 10-K · filed 2023-03-30 |
| 2021-09-30 | $253.62M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $285.00M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $292.85M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $324.97M 10-K · filed 2022-02-28 |
| 2020-09-30 | $201.88M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $204.89M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $127.49M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $131.66M 10-K · filed 2021-03-18 |
| 2019-09-30 | $148.85M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $166.04M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $184.42M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $195.40M 10-K · filed 2020-03-16 |
| 2018-09-30 | $123.22M 10-Q · filed 2018-11-14 |
| 2017-12-31 | $18.96M 10-K · filed 2019-04-01 |